Stay updated on Lazertinib Combination in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedMilestone dates on the study page have been updated: 2025-12-24, 2025-12-18, and 2028-03-27 were added, while 2025-12-04, 2025-12-05, and 2026-06-03 were removed.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded a new Locations section listing state sites; removed the prior California through Washington location entries. The page revision was updated to v3.3.3.SummaryDifference0.7%

- Check23 days agoChange DetectedNew update dates appear in December 2025 (2025-12-05, 2025-12-04, 2025-12). November 2025 entries were removed; no changes to the core study details.SummaryDifference0.1%

- Check38 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no substantive study content changes are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1 on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a new recruitment site in Tainan, Taiwan (704) and updated the location listings with recent timestamps (2025-11-07 and 2025-11-06).SummaryDifference0.3%

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.